Ga-68 Macroaggregated albumin

N/A

Report date: 2025/11/26 17:10:55

Base Information

Drug NameGa-68 Macroaggregated albumin
Drug Alias NameGa68-MAA
ClassificationRadiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugsRadiation-emitting products > Nuclides > Gallium > 68Ga +[4] 
Mechanisms of ActionEmission-computed tomography enhancersRadionuclide imaging enhancersPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsProstatic HyperplasiaCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBrest University Hospital CentreUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesBrest University Hospital Centre
Inactive CompaniesUniversity Of North Carolina At Chapel Hill
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A